CG-Well Intervention for Caregivers of Traumatic Brain Injury Patients
(CG-Well Trial)
Trial Summary
What is the purpose of this trial?
After injury, survivors of msTBI depend on informal family caregivers. Upwards of 77% of family caregivers experience poor outcomes, such as adverse life changes, poor health related quality of life, and increased depressive symptoms. Caregivers frequently report minimal support or training to prepare them for their new role. Periods of care transitions, such as ICU discharge, are most difficult. The majority (93%) of previously developed caregiver and caregiver/survivor dyad interventions after msTBI focus on providing information or practical skills to either survivors, or to long-term caregivers (\>6 months post injury), rather than education, support, and skill-building that the new caregiver may use proactively that will benefit the dyad acutely after injury. The Aims of this proposal are to: (1) Determine feasibility, satisfaction, and data trends of CG-Well; and (2) Understand how baseline psychosocial risk factors affect response to CG-Well compared to an Information, Support, and Referral control group. To accomplish this, I will first enroll 6-10 caregivers and tailor CG-well until each finds the intervention acceptable, appropriate, and feasible. I will then enroll 100 (50/group) dyads and determine satisfaction ratings, recruitment, retention, and treatment fidelity of CG-Well. Additionally, I will determine if caregivers report reductions in depressive symptoms and improvements in life changes as a result of improvements in task difficulty and threat appraisal in CG-Well compared to ISR at six months. Information obtained in Aims 1 and 2 will be used to plan a larger Phase III trial of CG-Well. Completing these Aims and the training plan will improve outcomes of caregivers and downstream outcomes of survivors of msTBI, and provide me with the skillset necessary to become an independent researcher who can develop and test high-impact, high-fidelity, sustainable interventions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment CG-Well for caregivers of traumatic brain injury patients?
The CG-Well program is designed to support caregivers of traumatic brain injury patients, and its development involved feedback from experts and caregivers to improve its effectiveness. Additionally, similar interventions, like Counselor-Assisted Problem Solving, have shown to improve caregiver adaptation after brain injury, suggesting that structured support programs can be beneficial.12345
Is the CG-Well Intervention safe for caregivers of traumatic brain injury patients?
What makes the CG-Well treatment unique for caregivers of traumatic brain injury patients?
Eligibility Criteria
This trial is for adult caregivers of patients with moderate to severe traumatic brain injuries (msTBI) that occurred less than 2 weeks ago. Both the caregiver and patient must be over 18, speak English, and the patient should have a GCS score between 3-12 after resuscitation. Those not expected to survive, pregnant individuals, prisoners, or those with conditions like substance abuse or major neurological/mental health disorders cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Caregivers participate in the CG-Well intervention, which includes web and phone-based psychosocial support and education
Follow-up
Participants are monitored for satisfaction, retention, and changes in depressive symptoms and life changes
Treatment Details
Interventions
- CG-Well
- Information Support & Referral (ISR)
CG-Well is already approved in United States for the following indications:
- Support for caregivers of acute moderate to severe traumatic brain injuries
Find a Clinic Near You
Who Is Running the Clinical Trial?
Natalie Kreitzer
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator